Is euthyroidism within reach for all?

References

• Jonklaas J. Optimal thyroid hormone replacement. Endocr Rev. 2022;43(2):366–404. doi: 10.1210/endrev/bnab031
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi: 10.1210/jcem.87.2.8182
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Bianco, AC, Bauer, AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid: Offic J Am Thyroid Association. 2014;24(12):1670–1751. doi: 10.1089/thy.2014.0028
   PubMed Web of Science ®Google Scholar
• Bianco AC, Bao Y, Antunez Flores O, et al. Levothyroxine treatment adequacy and formulation changes in patients with hypothyroidism: a retrospective study of real-world data from the United States. Thyroid®. 2023;33(8):940–949. doi: 10.1089/thy.2022.0382
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 2019;7(6):473–483. doi: 10.1016/S2213-8587(18)30371-1
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Davidson B, Bhagat S, et al. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA. 2008;299(7):769–777. doi: 10.1001/jama.299.7.769
   PubMed Web of Science ®Google Scholar
• Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. doi: 10.1371/journal.pone.0022552
   PubMed Web of Science ®Google Scholar
• Alevizaki M, Mantzou E, Cimponeriu AT, et al. Ist TSH ein geeigneter Indikator für eine adäquate Schilddrüsenhormon-Substitution? Wien Klin Wochenschr. 2005;117(18):636–640. doi: 10.1007/s00508-005-0421-0
   PubMedGoogle Scholar
• Jonklaas J, Bianco, AC, Cappola, AR, et al. Evidence-based use of levothyroxine/liothyronine Combinations in treating hypothyroidism: a consensus document. Thyroid: Offic J Am Thyroid Association. 2021;31(2):156–182. doi: 10.1089/thy.2020.0720
   PubMed Web of Science ®Google Scholar
• Casula S, Ettleson MD, Bianco AC. Are we restoring thyroid hormone signaling in levothyroxine-treated patients with residual symptoms of hypothyroidism? Endocr Pract. 2023;29(7):581–588. doi: 10.1016/j.eprac.2023.04.003
   PubMed Web of Science ®Google Scholar
• Werneck de Castro JP, Fonseca TL, Ueta CB, et al. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest. 2015;125(2):769–781. doi: 10.1172/JCI77588
   PubMed Web of Science ®Google Scholar
• Jo S, Fonseca TL, Bocco BMLC, et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J Clin Invest. 2019;129(1):230–245. doi: 10.1172/JCI123176
   PubMed Web of Science ®Google Scholar
• Su W, Zhao L, Bao S, et al. Alterations in Gray matter Morphology and Functional Connectivity in adult patients with newly diagnosed untreated hypothyroidism. Thyroid®. 2023;33(7):791–803. doi: 10.1089/thy.2022.0476
   PubMed Web of Science ®Google Scholar
• Cramon PK, Bjorner JB, Groenvold M, et al. Implementation of thyroid-related patient-reported outcomes in routine clinical practice. Front Endocrinol. 2022;13:1000682. doi: 10.3389/fendo.2022.1000682
   PubMedGoogle Scholar
• Zulewski H, Muller B, Exer P, et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82(3):771–776. doi: 10.1210/jc.82.3.771
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997;12(9):544–550. doi: 10.1046/j.1525-1497.1997.07109.x
   PubMed Web of Science ®Google Scholar
• Feng X, Jiang Y, Meltzer P, et al. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol. 2000;14(7):947–955. doi: 10.1210/mend.14.7.0470
   PubMedGoogle Scholar
• Massolt ET, Chaker L, Visser TJ, et al. Serum microRNA profiles in athyroid patients on and off levothyroxine therapy. PLoS One. 2018;13(4):e0194259. doi: 10.1371/journal.pone.0194259
   PubMed Web of Science ®Google Scholar
• Saravanan P, Chau W-F, Roberts N, et al. Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57(5):577–585. doi: 10.1046/j.1365-2265.2002.01654.x
   PubMed Web of Science ®Google Scholar
• Wekking EM, Appelhof BC, Fliers E, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;153(6):747–753. doi: 10.1530/eje.1.02025
   PubMed Web of Science ®Google Scholar
• Samuels MH, Kolobova I, Niederhausen M, et al. Effects of altering levothyroxine (L-T4) doses on quality of life, mood, and cognition in L-T4 treated subjects. J Clin Endocrinol Metab. 2018;103(5):1997–2008. doi: 10.1210/jc.2017-02668
   PubMed Web of Science ®Google Scholar
• Samuels MH, Kolobova I, Niederhausen M, et al. Effects of altering levothyroxine dose on energy expenditure and body composition in subjects treated with LT4. J Clin Endocrinol Metab. 2018;103(11):4163–4175. doi: 10.1210/jc.2018-01203
   PubMed Web of Science ®Google Scholar
• Eskelinen SI, Vahlberg TJ, Isoaho RE, et al. Associations of thyroid-stimulating hormone and free thyroxine concentrations with health and life satisfaction in elderly adults. Endocr Pract. 2007;13(5):451–457. doi: 10.4158/EP.13.5.451
   PubMedGoogle Scholar
• Akirov A, Fazelzad R, Ezzat S, et al. A systematic review and meta-analysis of patient preferences for combination thyroid hormone treatment for hypothyroidism. Front Endocrinol. 2019;10:477. doi: 10.3389/fendo.2019.00477
   PubMed Web of Science ®Google Scholar
• Ettleson MD, Raine A, Batistuzzo A, et al. Brain fog in hypothyroidism: understanding the patient’s perspective. Endocr Pract. 2022;28(3):257–264. doi: 10.1016/j.eprac.2021.12.003
   PubMed Web of Science ®Google Scholar
• Samuels MH, Bernstein LJ. Brain fog in hypothyroidism: what is it, how is it measured, and what can be Done about it. Thyroid: Offic J Am Thyroid Association. 2022;32(7):752–763. doi: 10.1089/thy.2022.0139
   PubMed Web of Science ®Google Scholar
• Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006;91(7):2624–2630. doi: 10.1210/jc.2006-0099
   PubMed Web of Science ®Google Scholar
• Boeving A, Paz-Filho G, Radominski, RB, et al. Low-normal or high-normal thyrotropin target levels during treatment of hypothyroidism: a prospective, comparative study. Thyroid: Offic J Am Thyroid Association. 2011;21(4):355–360. doi: 10.1089/thy.2010.0315
   PubMed Web of Science ®Google Scholar
• Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623–1629. doi: 10.1210/jc.2008-1301
   PubMed Web of Science ®Google Scholar
• Shakir MKM, Brooks DI, McAninch EA, et al. Comparative effectiveness of levothyroxine, desiccated thyroid extract, and levothyroxine+Liothyronine in hypothyroidism. J Clin Endocrinol Metab. 2021;106(11):e4400–e4413. doi: 10.1210/clinem/dgab478
   PubMed Web of Science ®Google Scholar
• DiStefano J, Jonklaas J. Predicting Optimal combination LT4 + LT3 therapy for hypothyroidism based on residual thyroid function. Front Endocrinol. 2019;10:746. doi: 10.3389/fendo.2019.00746
   PubMed Web of Science ®Google Scholar
• Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90(5):2666–2674. doi: 10.1210/jc.2004-2111
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Kažanavičius G, Žalinkevičius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424–429. doi: 10.1056/NEJM199902113400603
   PubMed Web of Science ®Google Scholar
• Clyde PW, Harari AE, Getka EJ, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290(22):2952–2958. doi: 10.1001/jama.290.22.2952
   PubMed Web of Science ®Google Scholar
• Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab. 2005;90(2):805–812. doi: 10.1210/jc.2004-1672
   PubMed Web of Science ®Google Scholar
• Jansen HI, Boelen A, Heijboer AC, et al. Hypothyroidism: the difficulty in attributing symptoms to their underlying cause. Front Endocrinol. 2023;14:1130661. doi: 10.3389/fendo.2023.1130661
   PubMed Web of Science ®Google Scholar
• Bould H, Panicker V, Kessler D, et al. Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity. Fam Pract. Fam Pract. 2012;29(2):163–167. doi: 10.1093/fampra/cmr059
   PubMed Web of Science ®Google Scholar
• Perros P, Nagy EV, Papini E, et al. Hypothyroidism and somatization: results from E-Mode patient self-assessment of thyroid therapy, a cross-sectional, international online patient survey. Thyroid®. 2023;33(8):927–939. doi: 10.1089/thy.2022.0641
   PubMed Web of Science ®Google Scholar
• Rezaei S, Abedi P, Maraghi E, et al. The effectiveness of cognitive- behavioral therapy on quality of life in women with hypothyroidism in the reproductive age: a randomized controlled trial. Thyroid Res. 2020;13(1):6. doi: 10.1186/s13044-020-00080-z
   PubMed Web of Science ®Google Scholar
• Peterson SJ, Cappola, AR, Castro, MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid: Offic J Am Thyroid Association. 2018;28(6):707–721. doi: 10.1089/thy.2017.0681
   PubMed Web of Science ®Google Scholar
• Perros P, Hegedüs L, Nagy, EV, et al. The impact of hypothyroidism on satisfaction with care and treatment and everyday living: results from E-Mode patient self-assessment of thyroid therapy, a cross-sectional, international online patient survey. Thyroid: Offic J Am Thyroid Association. 2022;32(10):1158–1168. doi: 10.1089/thy.2022.0324
   PubMed Web of Science ®Google Scholar
• Ettleson MD, Ibarra S, Wan W, et al. Demographic, healthcare access, and dietary factors associated with thyroid hormone treatments for hypothyroidism. J Clin Endocrinol Metab. 2023. doi:10.1210/clinem/dgad331.
   Web of Science ®Google Scholar
• Mehuys E, Lapauw B, T’Sjoen G, et al. Investigating levothyroxine use and Its Association with thyroid health in patients with hypothyroidism: a community pharmacy study. Thyroid®. 2023;33(8):918–926. doi: 10.1089/thy.2023.0066
   PubMed Web of Science ®Google Scholar
• Russell W, Harrison RF, Smith N, et al. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab. 2008;93(6):2300–2306. doi: 10.1210/jc.2007-2674
   PubMed Web of Science ®Google Scholar
• Saravanan P, Siddique H, Simmons D, et al. Twenty-four hour hormone profiles of TSH, free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp Clin Endocrinol Diabetes. 2007;115(4):261–267. doi: 10.1055/s-2007-973071
   PubMed Web of Science ®Google Scholar
• Köhrle J, Lehmphul I, Pietzner M, et al. 3,5-T2—A janus-faced thyroid hormone metabolite exerts both canonical T3-mimetic endocrine and intracrine hepatic action. Front Endocrinol. 2019;10:787. doi: 10.3389/fendo.2019.00787
   PubMed Web of Science ®Google Scholar
• Deshpande PR, Rajan S, Sudeepthi B, et al. Patient-reported outcomes: a new era in clinical research. Perspect Clin Res. 2011;2(4):137–144. doi: 10.4103/2229-3485.86879
   PubMedGoogle Scholar
• Mammen JS, Cooper DS. Symptoms in patients being treated for hypothyroidism: new data in a continuing controversy. Thyroid: Offic J Am Thyroid Association. 2023;33(8):887–889. doi: 10.1089/thy.2023.0307
   PubMed Web of Science ®Google Scholar